We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

A vaccine to protect babies and older adults against a common but potentially dangerous respiratory infection is set to be ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...

KIRKLAND, QC, Sept. 19, 2024 /CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in ...

KIRKLAND, QC, Sept. 19, 2024 /CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in older ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Chennai sees rise in viral respiratory infections, especially among children, with persistent cough lasting weeks, prompting flu vaccine recommendation.

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

Vaccines for flu and COVID-19 also protect expectant parents from serious symptoms. Pregnant people are more likely to need ...